All systems go for AFT Pharmaceuticals

All systems go for AFT Pharmaceuticals
Hartley Atkinson: negative economy won't impact growth. (Image: Supplied)
Brent Melville
AFT Pharmaceuticals expects to make inroads into the Australian market on the strength of its new Maxigesic sinus and pain treatment and hot drink sachet products.Product sales in Australia have steadily improved after the listed pharmaceutical group's successful legal appeal against British-based consumer products giant Reckitt Benckiser, allowing AFT to compare its products with paracetamol and ibuprofen in its advertising.That helped push overall product sales and royalties up by 30% during the half year to September 2022, though first-h...

More Markets

NZ sharemarket flat despite export growth
Markets Market close

NZ sharemarket flat despite export growth

The NZ sharemarket dipped as Fletcher Building shares fell further.

Tom Raynel 25 Jun 2025
FMA to focus on private market offers
Markets

FMA to focus on private market offers

The FMA is worried about unsophisticated investors taking the bait.

Pattrick Smellie 25 Jun 2025
Xero splashes $4.1b for 'step-change' US acquisition
Markets

Xero splashes $4.1b for 'step-change' US acquisition

Buying Melio gives Xero a leg-up in the crucial US SME market.

Pattrick Smellie 25 Jun 2025
Chorus broadband expansion makes priority list
Infrastructure

Chorus broadband expansion makes priority list

Chorus claims $17 billion NZ Inc gain for a $3b spend.

Pattrick Smellie 25 Jun 2025